
Mark S. Blouin
Examiner (ID: 14771, Phone: (571)272-7583 , Office: P/2687 )
| Most Active Art Unit | 2627 |
| Art Unit(s) | 2686, 2687, 2627, 2653 |
| Total Applications | 1769 |
| Issued Applications | 1539 |
| Pending Applications | 7 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8490074
[patent_doc_number] => 20120289481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/463951
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16476
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463951 | COMPOSITIONS AND METHODS FOR TREATING CANCER | May 3, 2012 | Abandoned |
Array
(
[id] => 8490477
[patent_doc_number] => 20120289884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'Fused Ring Diarylamino Photosensitizers for Phototherapy'
[patent_app_type] => utility
[patent_app_number] => 13/463861
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 42426
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463861 | Fused Ring Diarylamino Photosensitizers for Phototherapy | May 3, 2012 | Abandoned |
Array
(
[id] => 9518994
[patent_doc_number] => 20140155486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Administration of Iloprost as Aerosol Bolus'
[patent_app_type] => utility
[patent_app_number] => 14/061525
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10239
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14061525
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/061525 | Administration of Iloprost as Aerosol Bolus | Apr 25, 2012 | Abandoned |
Array
(
[id] => 11915305
[patent_doc_number] => 09783482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Antiviral compositions directed against the influenza virus nucleoprotein'
[patent_app_type] => utility
[patent_app_number] => 14/112987
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 1
[patent_no_of_words] => 15090
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112987
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112987 | Antiviral compositions directed against the influenza virus nucleoprotein | Apr 19, 2012 | Issued |
Array
(
[id] => 8490205
[patent_doc_number] => 20120289612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'Composite Material and Method for Producing the Same'
[patent_app_type] => utility
[patent_app_number] => 13/446618
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13633
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446618 | Composite Material and Method for Producing the Same | Apr 12, 2012 | Abandoned |
Array
(
[id] => 8442319
[patent_doc_number] => 20120258936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'INOSITOL HEXAKISPHOSPHATE ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/441017
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8154
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/441017 | INOSITOL HEXAKISPHOSPHATE ANALOGS AND USES THEREOF | Apr 5, 2012 | Abandoned |
Array
(
[id] => 8464699
[patent_doc_number] => 20120269867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/439615
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16063
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439615
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439615 | METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS | Apr 3, 2012 | Abandoned |
Array
(
[id] => 8430965
[patent_doc_number] => 20120252840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Method of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/438964
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8396
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438964
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438964 | Method of Treating Cancer | Apr 3, 2012 | Abandoned |
Array
(
[id] => 9518880
[patent_doc_number] => 20140155372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'COMBINATIONS OF AKT AND MEK INHIBITOR COMPOUNDS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/009320
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 19604
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009320 | Combinations of AKT and MEK inhibitor compounds, and methods of use | Mar 29, 2012 | Issued |
Array
(
[id] => 9319363
[patent_doc_number] => 20140051701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'METHODS OF TREATING A DISEASE OR CONDITION OF THE CENTRAL NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/002536
[patent_app_country] => US
[patent_app_date] => 2012-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28762
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002536
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002536 | METHODS OF TREATING A DISEASE OR CONDITION OF THE CENTRAL NERVOUS SYSTEM | Mar 1, 2012 | Abandoned |
Array
(
[id] => 8253084
[patent_doc_number] => 20120157410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND CHOLINESTERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/399079
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 44006
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157410.pdf
[firstpage_image] =>[orig_patent_app_number] => 13399079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/399079 | COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND CHOLINESTERASE INHIBITORS | Feb 16, 2012 | Abandoned |
Array
(
[id] => 9162161
[patent_doc_number] => 20130310438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 13/982052
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20111
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982052 | Bicyclic compound and use thereof for medical purposes | Jan 25, 2012 | Issued |
| 13/357122 | ANTIMICROBIAL COMPOSITIONS AND METHODS | Jan 23, 2012 | Abandoned |
Array
(
[id] => 9589386
[patent_doc_number] => 08778926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Compounds, pharmaceutical compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/354356
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32607
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354356
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/354356 | Compounds, pharmaceutical compositions and uses thereof | Jan 19, 2012 | Issued |
Array
(
[id] => 9108405
[patent_doc_number] => 20130281537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'AQUEOUS LIQUID BROMFENAC COMPOSITION HAVING PRESERVATIVE EFFICACY'
[patent_app_type] => utility
[patent_app_number] => 13/978258
[patent_app_country] => US
[patent_app_date] => 2012-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15015
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978258 | Aqueous liquid bromfenac composition having preservative efficacy | Jan 17, 2012 | Issued |
Array
(
[id] => 10063856
[patent_doc_number] => 09102687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Ingenol-3-acylates III and ingenol-3-carbamates'
[patent_app_type] => utility
[patent_app_number] => 13/996989
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49021
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996989
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996989 | Ingenol-3-acylates III and ingenol-3-carbamates | Dec 21, 2011 | Issued |
Array
(
[id] => 9094916
[patent_doc_number] => 20130274228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'CONCOMITANT DRUG FOR IMPROVING COGNITIVE FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/977190
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4458
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/977190 | CONCOMITANT DRUG FOR IMPROVING COGNITIVE FUNCTION | Dec 14, 2011 | Abandoned |
Array
(
[id] => 13151741
[patent_doc_number] => 10092573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Gastric and colonic formulations and methods for making and using them
[patent_app_type] => utility
[patent_app_number] => 13/993294
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14286
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993294 | Gastric and colonic formulations and methods for making and using them | Dec 12, 2011 | Issued |
Array
(
[id] => 9384710
[patent_doc_number] => 20140088192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'SUBCUTANEOUSLY INFUSIBLE LEVODOPA PRODRUG COMPOSITIONS AND METHODS OF INFUSION'
[patent_app_type] => utility
[patent_app_number] => 13/992105
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42128
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992105
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992105 | SUBCUTANEOUSLY INFUSIBLE LEVODOPA PRODRUG COMPOSITIONS AND METHODS OF INFUSION | Dec 11, 2011 | Abandoned |
Array
(
[id] => 8510803
[patent_doc_number] => 20120310211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'PHENTERMINE LIQUID DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 13/315579
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6997
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/315579 | PHENTERMINE LIQUID DOSAGE FORM | Dec 8, 2011 | Abandoned |